Weve developed and shown proof-of-concept for a gene therapy for one of the most common forms of retinitis pigmentosa, said William Beltran, D.V.M., Ph.D., of the University of Pennsylvania School of Veterinary Medicine, Philadelphia, a lead author of the study, which appears online today in the